anomicielles curcumin in metabolic syndrome

Phase 3

Recruiting

• Conditions: Metabolic Syndrom.; Metabolic syndrome; E88.81

• Registration Number: IRCT20150815023617N4
• Lead Sponsor: ational Nutrition And Food Technology Research Institute of Iran

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Last Update Posted: 11 September 2018

Recruitment & Eligibility

• Status: Recruiting
• Sex: All
• Target Recruitment: 23

Inclusion Criteria

Tendency for participation
Age between 18-70 years old
BMI between 25-40 kg/m2
Having metabolic syndrome according to the NCEP ATP III definition(if patient have three or more of the following five criteria): waist circumference over 120 cm (men) or 89 cm (women), blood pressure over 130/85 mmHg, fasting triglyceride (TG) level over 150 mg/dl, fasting high-density lipoprotein (HDL) cholesterol level less than 40 mg/dl (men) or 50 mg/dl (women) and fasting blood sugar over 100 mg/dl.

Exclusion Criteria

Not provided

Study & Design

• Study Type: interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Adiponectin. Timepoint: Baseline and end of the study. Method of measurement: ELISA method.;Total Antioxidant Capacity(TAC). Timepoint: Baseline and end of the study. Method of measurement: Enzymatic colorimetric analysis method.;Malondialdehyde(MDA). Timepoint: Baseline and end of the study. Method of measurement: Enzymatic colorimetric analysis method.;High-sensitivity C-reactive protein(hs-CRP). Timepoint: Baseline and end of the study. Method of measurement: ELISA method.;Nuclear factor-?B. Timepoint: Baseline and end of the study. Method of measurement: ELISA method.